Search Results for: LYN

137 interactions involving LYN - LYN proto-oncogene, Src family tyrosine kinase found:

Sort by: Symbol Number of Pathways Number of Drugs Number of Diseases
Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
BANK1 B cell scaffold protein with ankyrin repeats 1
CBLC Cbl proto-oncogene C
ERBB3 erb-b2 receptor tyrosine kinase 3
  • Tucatinib
  • Lethal congenital contractural syndrome (LCCS)
  • Type I diabetes mellitus
ERBB4 erb-b2 receptor tyrosine kinase 4
  • Afatinib
  • Fostamatinib
  • Brigatinib
  • Zanubrutinib
GAB3 GRB2 associated binding protein 3
HCLS1 hematopoietic cell-specific Lyn substrate 1
IGHA1 immunoglobulin heavy constant alpha 1
LIME1 Lck interacting transmembrane adaptor 1
MAP4K1 mitogen-activated protein kinase kinase kinase kinase 1
  • Fostamatinib
MS4A1 membrane spanning 4-domains A1
  • Rituximab
  • Ibritumomab tiuxetan
  • Tositumomab
  • Ofatumumab
  • Obinutuzumab
  • Technetium Tc-99m nofetumomab merpentan
  • Ocrelizumab
NDFIP2 Nedd4 family interacting protein 2
NEDD9 neural precursor cell expressed, developmentally down-regulated 9
PPP1R8 protein phosphatase 1 regulatory subunit 8
PRAM1 PML-RARA regulated adaptor molecule 1
SKAP1 src kinase associated phosphoprotein 1
TRIM55 tripartite motif containing 55
UNC119 unc-119 lipid binding chaperone

Page 7 out of 7 pages